Delivery Order SPE2DB22D2214-SPE2DB25FS5TD
- Not listed
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $52,548.97 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $41,926.54 for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This is a firm fixed-price, non-set-aside award that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $17,816.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,082.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on August 27, 2025, with completion targeted for August 28, 2025. This is a non-set-aside, competitively awarded delivery order performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,076.77 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 22, 2025. The award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters location, which also serves as the place of performance for...
- The Defense Logistics Agency awarded a $34,278.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award with an ultimate completion date of September 15, 2025, and performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5TDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,415.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999.999 billion through December 2026. The product is being delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal medical procurement needs. As a child order under the larger IDC vehicle, this delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier for military and veteran healthcare systems. TRELEGY ELLIPTA is a combination respiratory medication commonly used for chronic obstructive pulmonary disease management, reflecting the breadth of therapeutic medications the company supplies through its DLA contracts. AmerisourceBergen's comprehensive pharmaceutical support vehicle enables the company to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/14/25 |